MAIA Biotechnology | Investor Presentation Deck | 39 slides · page 23 of 39
The slide outlines a multi-stage clinical trial design (Part A/B to Part C) involving immune activation with various checkpoint inhibitors.
Pitch deck · roadmap · plan_implementation · balanced density
Slide locked Sign in to view
Slide schematic 4/4
diagram 1/1 paragraph 1/1 source-note 1/1 title 1/1
Components 4
process paragraph source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1